Kiniksa Pharmaceuticals International, plc Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value
Kiniksa Pharmaceuticals International, plc (KNSA) had Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value of $278.14 million as of 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate · last filed 2026-04-28
- 2026-03-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $278.14M.
- 2025-12-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $248.48M.
- 2024-12-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $60.05M.
| Period end | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value |
|---|---|
| 2026-03-31 | $278.14M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $248.48M 10-Q · filed 2026-04-28 |
| 2024-12-31 | $60.05M 10-K · filed 2026-02-24 |